Informazione:
Errore:
ID
34169
Descrizione
Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01395056
collegamento
https://clinicaltrials.gov/show/NCT01395056
Keywords
versioni (1)
- 15/01/19 15/01/19 -
Titolare del copyright
see on clinicaltrials.gov
Caricato su
15 gennaio 2019
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility Breast Neoplasms NCT01395056
Eligibility Breast Neoplasms NCT01395056
- StudyEvent: Eligibility
Similar models
Eligibility Breast Neoplasms NCT01395056
- StudyEvent: Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
ID.1
Item
failure to anthracycline and/or taxol chemotherapy;
boolean
ID.2
Item
metastatic tumor is histologically confirmed by immunohistochemical staining to be er-negative and pr-negative. fish testing for her-2-negative;
boolean
ID.3
Item
metastatic tumor can not be removed through surgery procedure;
boolean
ID.4
Item
an eastern cooperative oncology group (ecog) performance status of 0-2;
boolean
ID.5
Item
normal cardiac, hepatic, renal and bone marrow functions;
boolean
ID.6
Item
life expectancy ≥3 months.
boolean
ID.7
Item
central nervous system metastases;
boolean
ID.8
Item
serious or uncontrolled concurrent medical illness;
boolean
ID.9
Item
history of other malignancies;
boolean
ID.10
Item
having been enrolled in some other clinal trials within a month;
boolean